3Miura M,Kagaya H,Tada H. Enantioselective disposition of rabeprazole in relation to CYP2C19 genotypes[J].British Journal of Clinical Pharmacology,2006,(03):315-320.doi:10.1111/j.1365-2125.2005.02566.x.
4Pace F,Pallotta S,Casalini S. A review of rabeprazole in the treatment of acid-related diseases[J].Ther Clin Risk Manag,2007,(03):363-379.
5Hsu Y C,Yang T H,Hsu W L. Mosapride as an adjunct to lansoprazole for symptom relief of reflux oesophagitis[J].British Journal of Clinical Pharmacology,2010,(02):171-179.
3Corinaldesi R,Valentini M,Belaiche J,et al.Pantoprazole and omeprazole in the treatment of reflux oesophagitis:a European multicentre study[J].Aliment Pharmacol Ther,1995,9(6):667-671.
4Jaspersen D,Diehl KL,Schoeppner H,et al.A comparison of omeprazole,lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis[J].Aliment Pharmacol Ther,1998,12(1):49-52.
5Dupas JL,Houcke P,Samoyeau R,et al.Pantoprazole versus lansoprazole in French patients with reflux esophagitis[J].Gastroenterol Clin Biol,2001,25(3):245-250.
6M(o)ssner J,H(o)lscher AH,Herz R,et al.A double-blind study of pantoprazole and omeprazole in the treatment of reflux oesophagitis:a multicentre trial[J].Aliment Pharmacol Ther,1995,9(3):321-326.
7Mee AS,Rowley JL.Rapid symptom relief in reflux oesophagitis:a comparison of lansoprazole and omeprazole[J].Aliment Pharmacol Ther,1996,10(5):757-763.
8Castell DO,Richter JE,Robinson M,et al.Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis.The Lansoprazole Group[J].Am J Gastroenterol,1996,91(9):1749-1757.
9Hatlebakk JG,Berstad A,Carling L,et al.Lansoprazole versus omeprazole in short-term treatment of reflux oesophagitis.Results of a Scandinavian multicentre trial[J].Scand J Gastroenterol,1993,28(3):224-228.
10Vcev A,Stimac D,Vceva A,et al.Lansoprazole versus omeprazole in the treatment of reflux esophagitis[J].Acta Med Croatica,1997,51(3):171-174.
3Abu-Sneineh A, Tam W. Schoeman M,et al. The effects of high-dose esomeprazole on gastric and oesophageal acid exposure and molecular markers in Barrett s oesophagus [ J ]. Aliment Pharmacol Ther, 2010, 32(8) : 1023-1030.
